final program

 

Click here to download Final Program as a pdf.


Saturday,
July 27, 2013
Sunday,
July 28, 2013
Monday,
July 29, 2013
Oral Presentations Oral Presentations Oral Presentations
Poster Sessions Poster Sessions Poster Sessions

 

Monday, July 29, 2013

08:30-10:45   HALL A
 

PL14    Plenary Session:
THE KIDNEY, BLOOD PRESSURE AND HYPERTENSION MANAGEMENT
 

Chairs:
W.S. Aronow, Valhalla, NY, USA
A.H. Danser, Rotterdam, The Netherlands

 
08:30 ROLE OF INGESTION-TIME OF RENIN-ANGIOTENSIN BLOCKADE FOR REDUCING BLOOD PRESSURE AND CARDIOVASCULAR RISK (Invited Lecture)
R.C. Hermida, D.E. Ayala, University of Vigo, Vigo, Spain
393
08:45 RENAL DENERVATION IN HYPERTENSION AND MORE? (Invited Lecture)
F. Mahfoud, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany
 
394
09:00 DUAL RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITION: TOO MUCH OF A GOOD THING? (Invited Lecture)
A.H. Danser, Erasmus Medical Center, Rotterdam, The Netherlands
390
09:15 OPTIMAL BLOOD PRESSURE GOALS IN PATIENTS AT HIGH RISK FOR CARDIOVASCULAR EVENTS (Invited Lecture)
W.S. Aronow, New York Medical College, Valhalla, NY, USA
391
09:30 NOVEL TECHNOLOGIES TO MANAGE BLOOD PRESSURE IN PATIENTS WITH AUTONOMIC DYSFUNCTION (Invited Lecture)
A. Diedrich, F. Baudenbacher, J. Jordan, J. Tank, K. Heusser, S. Raj,
D. Robertson, I. Biaggioni
Vanderbilt University School of Medicine, Nashville, TN, USA
392
09:45 USE OF AMBULATORY BLOOD PRESSURE MONITOR (ABPM) FOR GUIDING CARDIAC PATIENTS MANAGEMENT (Invited Lecture)
Y. Charuzi, R. Gao, J. Mirocha, UCLA School of Medicine, CA, USA
395
10:00 CHRONOTHERAPY WITH LOW-DOSE ASPIRIN FOR PREVENTION OF COMPLICATIONS IN PREGNANCY (Invited Lecture)
D.E. Ayala, R.C. Hermida, Campus Universitario, Vigo, Spain
396
10:15 HYPONATREMIA IN PATIENTS WITH ACUTE DECOMPENSATED HEART FAILURE TREATED WITH ULTRAFILTRATION
J.A. Caballero, I. Dumitru, J.M. Mack, J.R. Windle, B.D. Lowes, E. Rome, E. Raichlin, University of Nebraska Medical Center, Omaha, Nebraska, USA
398
10:30 PROCEDURAL PARAMETERS DURING RENAL DENERVATION AND CHANGE OF BLOOD PRESSURE IN PATIENTS WITH RESISTANT HYPERTENSION
C. Ukena, F. Mahfoud, O. Adam, M. Dalinghoff, B. Cremers, M. Boehm Universitaetsklinikum des Saarlandes, Homburg/Saar, Germany
399
10:45 COFFEE BREAK, VISIT POSTERS AND EXHIBITION  
MONDAY, JULY 29, 2013
08:30-11:00   HALL B

 

PL15   Plenary Session:
ADVANCES IN THE TREATMENT AND MANAGEMENT OF HEART FAILURE

Chairs:
U. Elkayam, Los Angeles, USA
H.N. Sabbah, Detroit, MI, USA

 

08:30 SIMULTANEOUS MEASUREMENT OF MULTIPLE CIRCULATING microRNAS IMPROVES PROGNOSTICATION IN SUBJECTS WITH HEART FAILURE (Invited Lecture)
A. Bayes-Genis, J. Lupon, J.J. Leenders, S.J. Pinto-Sietsma, Y.M. Pinto
Heart Centre at the University of Amsterdam, Amsterdam, The Netherlands
400
08:45 A NEW THERAPY FOR DIASTOLIC HEART FAILURE (Invited Lecture)
E.M. Jeong, M.M. Monasky, L. Gu, D.M. Taglieri, B.G. Patel, H. Liu,
Q. Wang, I. Greener, R.J. Solaro, S.C. Dudley, University of Illinois at Chicago, Chicago, IL, USA
 
401
09:00 PARTIAL ADENOSINE A1-RECEPTOR AGONISTS FOR THE TREATMENT OF HEART FAILURE (Invited Lecture)
H.N. Sabbah, Henry Ford Heart & Vascular Institute, Detroit, MI, USA
 
402
09:15 ENHANCING GLUCOSE OXIDATION AS AN APPROACH TO TREAT 403 HEART FAILURE (Invited Lecture)
G. Lopaschuk, University of Alberta, Edmonton, AB, Canada
403
09:30 ULTRAFILTRATION IN THE TREATMENT OF VOLUME OVERLOAD DUE TO HEART FAILURE (Invited Lecture)
U. Elkayam, University of Southern California, Keck School of Medicine, Los Angeles, CA, USA
405
09:45 ROLE OF PERITONEAL DIALYSIS IN MANAGEMENT OF HEART FAILURE: AN UPDATE FOR 2013 (Invited Lecture)
A. Kazory, University of Florida, Gainesville, FL, USA
406
10:00

CATHETER ABLATION IN PATIENTS WITH ELECTRICAL STORM – BENEFIT OF A CLINICAL NETWORK (Invited Lecture)
T. Deneke, K. Nentwich, J. Krug, S. Kerber, A. Schade
University of Bochum, Bochum, Germany

089
10:15 BIOMARKER SOLUTIONS FOR HEART FAILURE AND COPD MANAGEMENT (Invited Lecture)
K. Lam, B.M. McManus, PROOF Center of Excellence, Vancouver, BC, Canada
407
10:30 PREDOMINANT DIFFERENTIAL CAUSE OF DYSPNEA IN ATRIAL FIBRILLATION AND COINCIDENT COPD. INFLAMMATION, LATENT ISCHEMIA AND MYOCARDIAL DYSFUNCTION, THROMBOGENESIS, APOPTOSIS AND CARDIOVASCULAR REMODELING OR RESPIRATORY IMPAIRMENT? (Invited Lecture)
I. Angomachalelis, G. Kyriazis, N.J. Angomachalelis, Aristotle University, School of Medicine, Thessaloniki, Macedonia, Greece
409
10:45 EFFICACY AND SAFETY OF IVABRADIN IN PATIENTS WITH IDIOPATHIC DILATED CARDIOMYOPATHY (Invited Lecture)
S. Chumburidze, Scientific Research Clinic of Therapy, Tbilisi, Rep. of Georgia
410
11:00 COFFEE BREAK, VISIT POSTERS AND EXHIBITION  
MONDAY, JULY 29, 2013
08:30 - 11:15   HALL C
  S33   Session:  
INTERVENTIONAL CARDIOLOGY / ANTITHROMBOTIC AND ANTIPLATELET THERAPY FOR PCI

Chairs:
T. Akasaka, Wakayama, Japan
T. Tomaru, Chiba, Japan
 
08:30 BENEFITS AND RISKS OF LONG-TERM DURATION OF DUAL ANTIPLATELET THERAPY AFTER DRUG-ELUTING STENTING: A META-ANALYSIS OF RANDOMIZED TRIALS
G. Ferrante, S.J. Park, H.S. Kim, K.W. Park, D.W. Park, M. Valgimigli
Istituto Clinico Humanitas, Rozzano, Italy
411
08:45 CHARACTERISTICS OF PATIENTS WITH POST PCI HYPER-RESPONSIVENESS TO CLOPIDOGREL
E. Asher, P. Anarado, R. Brauch, A. Ka Chun Chan, M. Mayuga, M. Bradley, D.I. Simon, T. Lassar
Case Medical Center, University Hospitals, Cleveland Ohio, USA
412
09:00 CO-EXISTENCE OF HYPO-RESPONSIVENESS TO ASPIRIN AND CLOPIDOGREL IN EMERGENCY ROOM IN PATIENTS WITH CORONARY ARTERY STENTING
R.K. Sharma, S.W. Erickson, R. Sharma, H.K. Reddy, D.J. Voelker,
H. Dod, V.N. Singh, E.I. Murgasen, J.D. Marsh
University of Arkansas for Medical Sciences, Little Rock, AR, USA
413
09:15 ANTIPLATELET DRUG RESISTENCE IN ASIAN POPULATION
G. Vijayaraghavan, P. Sadath
Kerala Institute of Medical Sciences, Trivandrum, Kerala, India
414
09:30 BLEEDING COMPLICATIONS WITH PERCUTANEOUS CORONARY INTERVENTION: A COMPARISON OF BIVALIRUDIN AND EPTIFIBATIDE
S. Kohli, R.J. Campbell, M.A. Kjelsberg, A.K. Saal
Henry Ford Hospital, Detroit, MI, USA
415
09:45 BLEEDING WITH CONCURRENT USE OF ANTICOAGULANTS IN TRANSRADIAL PERCUTANEOUS CORONARY INTERVENTION – THE BART ANALYSIS
S. Adusumalli
, A.K. Chagarlamudi, M. Patwardhan, G.S. Harris,
R. Daggubati, East Carolina Heart Institute, Greenville, NC, USA
416
10:00 MRI AND ELECTROCARDIOGRAM IN EVALUATION OF HOMOGENEOUS INFARCT, PATCHY MICROINFARCT AND THE COMBINATION
L. Do, M.W .Wilson, J. Murayama, C. Stillson, S.W. Hetts, M. Saeed University of California San Francisco, San Francisco, CA, USA
417
10:15 IMPACT OF RENAL INSUFFICIENCY ON 30-DAY OUTCOMES IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION TREATED WITH PRIMARY PERCUTANEOUS CORONARY INTERVENTION
K. Sakai, Y. Soga, M. Hyodo, T. Arita, S. Shirai, K. Ando, K. Kondo,
H. Yokoi, M. Iwabuchi, M. Nobuyoshi, Kokura Memorial Hospital, Kitakyushu, Japan
418
10:30 INDICATIONS AND SURVIVAL OF 90 YEAR OLDS UNDERGOING CORONARY ANGIOGRAPHY
S.A. Agha, M.S Sidhu, J. Rollor, J. Brown, S. Conley, N. Niles, D. Malenka, J. Robb, Dartmouth Hitchcock Medical Center, Geisel School of Medicine, Lebanon NH, USA
419
10:45 EARLY STRINGENT GLYCEMIC CONTROL IMPROVES REPERFUSION IN PATIENTS WITH ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
Y.Y. Abdelmonem, Y. Sharaf, H. Kandil, S. El Tobgi
Kasr Alaini Medical School, Cairo, Egypt
420
11:00 COMPARING OUTCOMES IN MYOCARDIAL INFARCTION (NSTEMI) EARLY VERSUS DELAYED LEFT HEART CATHETERIZATION (COMED TRIAL)
M.A. Farooqui, S. Adusumalli, G. Harris, R. Daggubati
East Carolina University, Greenville, NC, USA
421
11:15 COFFEE BREAK, VISIT POSTERS AND EXHIBITION  
MONDAY, JULY 29, 2013
11:15 - 13:15   HALL A
  PL16   Plenary Session:  
CURRENT CONCEPTS AND FUTURE DIRECTIONS IN ISCHEMIC HEART DISEASE AND ACUTE CORONARY SYNDROMES

Chairs:
G.W. Barsness, Rochester, MN, USA
Y. Ueda, Osaka, Japan
 
11:15 THE COMPLICATED STEMI: WHAT TO DO WITH MULTIVESSEL DISEASE (Invited Lecture)
G.W. Barsness, Mayo Clinic, Rochester, MN, USA
422
11:30 FFR AT 2013: AN UPDATE (Invited Lecture)
E. Kaluski, Guthrie Health Services & NJ Medical School, Sayre, PA, USA
423
11:45 HIGH SENSITIVITY TROPONINS: A STEP FORWARD OR AN UNREQUESTED COMPLICATION? (Invited Lecture)
L. M. Biasucci, Policlinico A. Gemelli, Catholic University of the Sacred Heart Largo, Rome, Italy
424
12:00 WHY ACS OCCURS AND HOW WE CAN PREVENT IT (Invited Lecture)
Y. Ueda, Osaka Police Hospital, Tennoj-ku, Osaka, Japan
425
12:15 TRENDS IN MANAGEMENT AND OUTCOME OF PATIENTS WITH ACUTE CORONARY SYNDROMES IN THE LAST DECADE: THE ACS ISRAELI SURVEY (ACSIS) EXPERIENCE (Invited Lecture)
S. Gottlieb, Jerusalem, Israel
426
12:30 PREVENTION OF REPERFUSION INJURY IN PATIENTS WITH ST ELEVATION MYOCARDIAL INFARCTION: THE CGMP PATHWAY (Invited Lecture)
D. Garcia-Dorado, Vall d’Hebron University Hospital and Research Institute Universitat Autònoma de Barcelona, Barcelona, Spain
 
427
12:45 FEMORAL OR RADIAL ACCESS FOR PRIMARY PCI: A DILEMMA OF CHOICE (Invited Lecture)
A.N. Cheema, St. Michael’s Hospital, Toronto, ON, Canada
 
428
13:00 PROTECTIVE EFFECT OF TELMISARTAN AGAINST ENDOTHELIAL DYSFUNCTION AFTER CORONARY DRUG-ELUTING STENT IMPLANTATION IN HYPERTENSIVE PATIENTS (Invited Lecture)
M. Terashima, K. Nasu, H. Kaneda, M. Habara, H. Matsuo, T. Ito,
Y. Kinoshita, M. Kimura, T. Suzuki
Toyohashi Heart Center, Toyohashi, Japan
 
429
13:15 COFFEE BREAK, VISIT POSTERS AND EXHIBITION  
MONDAY, JULY 29, 2013
11:15-14:00   HALL B
 

S34    Session:
HEART FAILURE: NOVEL RISK FACTORS, BIOMARKERS, PREVENTION AND NEW TREATMENT OPTIONS
 

Chairs:
G. Lopaschuk, Edmonton, AB, Canada
S. Schaefer, Davis, CA, USA

 
11:15 INCIDENT HEART FAILURE MORTALITY ACCORDING TO RACE AND SEX AMONG OLDER ADULTS FROM THE CARDIOVASCULAR HEALTH STUDY
S. Parashar, R. Katz, N.L. Smith, A.A. Arnold, V. Vaccarino, N. Wenger, J.S. Gottdiener, Emory University, Atlanta, Georgia, USA
430
11:30 FACTORS AFFECTING MINNESOTA LIVING WITH HEART 431 FAILURE SCORE
V. Mundra, A. Trombley, R. Kacere
St John Medical Center, Tulsa, OK, USA
431
11:45 MARKED ELEVATION OF B-TYPE NATRIUETIC PEPTIDE IN PATIENTS WITH HEART FAILURE AND PRESERVED EJECTION FRACTION
S. Tate, A. Griem, C. Watt, S. Schaefer, University of California, Davis USA
432
12:00 RISK FACTORS FOR 30-DAY READMISSION FOR ACUTE DECOMPENSATED HEART FAILURE: A HOSPITAL BASED STUDY
R.F. Njoh, B. Njei, C. Moskowitz, A. Dutta, R. Vidhun, T. Genese
St. Mary’s Hospital, Waterbury, CT, USA
434
12:15 A META-ANALYSIS ON THE EFFECTS OF TOLVAPTAN IN PATIENTS WITH CHRONIC HEART FAILURE
P.C. Ines, F.L. Fernandez, F.L. Catalan, I.L. Celedonio, F.A. Atibagos
Adult Cardiology, Philippine Heart Center
435
12:30 PROTEINURIA AND RENAL DYSFUNCTION AS PREDICTORS OF DIASTOLIC DYSFUNCTION
P. Rodriguez-Lozano, W.I. Khalife, M. Morsy, S. Mutnuri, A. Khan
UTMB, Galveston, TX, USA
437
12:45 DIAGNOSTIC VALUE OF N -TERMINAL PROBNP BIOMARKER IN EVALUATION OF CONGESTIVE HEART FAILURE
R.K. Sharma, A. Aggarwal, S.W. Erickson, R. Sharma, D.J. Voelker,
H. Dod, H.K.Reddy
University of Arkansas for Medical Science, Little Rock Arkansas, USA
438
13:00 HYPERKALEMIA AMONG HOSPITALIZED PATIENTS WITH ACE INHIBITORS AND ANGIOTENSIN - II RECEPTOR BLOCKER THERAPY
J.B. Khanagavi, T. Gupta, J. Garg, T. Shah, W.S. Aronow
New York Medical College, Valhalla, NY, USA
439
13:15 VALUE OF STATINS IN CONGESTIVE HEART FAILURE PATIENTS WITH ELEVATED HIGH SENSITIVITY C-REACTIVE PROTEIN
H.S. Taha, H.G. Elhossary, A.A. Heiba Faculty of Medicine, Cairo University, Cairo, Egypt
073
13:30 FACTORS PREDICTING 6 MINUTE WALK TEST IN PATIENTS WITH STABLE HEART FAILURE
V. Mundra, A. Trombley, R. Kacere, St. John Medical Center, Tulsa, OK, USA
 
436
13:45 EPICARDIAL ADIPOSE TISSUE THICKNESS AS ASSESSED BY ECHOCARDIOGRAPHY & DIASTOLIC LEFT VENTRICULAR FUNCTION
M. Kaushik, V.M. Alla, A. Saurav, A. Smer, R. Madan, S. Khan, C. Hunter, M. Holmberg, S.M. Mohiuddin
Creighton University School of Medicine, Omaha NE, USA
433
14:00 LUNCH BREAK, VISIT POSTERS AND EXHIBITION  
MONDAY, JULY 29, 2013
11:15-14:15   HALL C

 

S35   Session:
OBESITY, METABOLIC SYNDROME AND DIABETES, BASIC AND CLINICAL

Chairs:
A.L. Klatsky, Oakland, CA, USA
J.J. Mahmarian, Houston, TX, USA

 

11:15 SCREENING FOR ASYMPTOMATIC CORONARY ARTERY DISEASE: SEEKING VALUE IN A MULTI-MODALITY WORLD (Invited Lecture)
J.J. Mahmarian, Methodist DeBakey Heart & Vascular Center, The Methodist Hospital, Houston, TX, USA
016
11:30 SILENCING CLC-3 PREVENTS APOPTOSIS INDUCED BY PALMITATE IN PREADIPOCYTES THROUGH THE ER STRESS PATHWAY, A POTENTIAL LINK BETWEEN OBESITY AND INSULIN RESISTANCE
Y.Y. Huang, J.Y. Du, H.S. Sun, Y.Y. Guan, G.L. Wang
Sun Yat-sen University, Guangzhou, Guangdong, People’s Republic of China
441
11:45 GLUCOSE-INSULIN-POTASSIUM IMPROVES CARDIAC PERFORMANCE VIA INHIBITING HEXOSAMINE BIOSYNTHESIS IN PATIENTS UNDERGOING CARDIOPUMONARY BYPASS
K. Zhao
, F. Fu, Y. Zhang, S.Q. Yu, Z.X. Jin, W.S. Chen, J.C. Liu, Q. Cui,
F. Gao, D.H. Yi
Xijing Hospital, Fourth Military Medical University, Xi’an, Shannxi, China
442
12:00 DOES DIABETES CAUSE ATRIAL FIBRILLATION?
M.M Ansari, S. Baghi, W. Park, S. Shah, S. Garyali, C. Nedelcu, K. Ong
NYP/BHC- Weill Cornell, USA
443
12:15 EPICARDIAL ADIPOSE TISSUE: PREDICTOR OF METABOLIC SYNDROME IN THE ELDERLY
M. Wu, Y. Yu, S. Sookhu, J.N. Makaryus, F. Bajwa, A. Supariwala,
F.A. Chaudhry, A.N. Makaryus, V. Suma
Hofstra North Shore LIJ School of Medicine, Manhasset, NY, USA
444
12:30 SYNERGISTIC RELATIONSHIP WITH THE RISK OF CARDIOVASCULAR EVENTS BETWEEN DIABETES AND AMBULATORY BLOOD PRESSURE
R.C. Hermida, D.E. Ayala, A. Mojon, J.R. Fernandez University of Vigo, Vigo, Spain
445
12:45 GLOBAL LONGITUDINAL STRAIN IS ALTERED IN DIABETES MELLITUS PATIENTS WITH NORMAL EJECTION FRACTION, STRATIFIED BY BMI: A SPECKLE TRACKING ECHOCARDIOGRAPHY STUDY
V. Di Bello, L. Conte, I. Fabiani, C. Cucco, R. Liga, V. Barletta, C. Bianchi, R. Miccoli, M.G .Delle Donne, M. Marian,i University of Pisa, Pisa, PI, Italy
446
13:00 BARIATRIC SURGERY VERSUS NON-SURGICAL TREATMENT FOR OBESITY: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
V.L. Gloy, M. Briel, D. Bhatt, S. Kashyap, P. Schauer, G. Mingrone,
H.C. Bucher, A.J. Nordmann University Hospital Basel, Switzerland
447
13:15 LEVELS OF OXIDATIVE STRESS AND ANTI-OXIDANT STATUS IN 448 DIABETES MELLITUS PATIENTS
V.S.N. Janaswamy, J. Maddury, M. Manohar, R. Sahay, Osmania Hospital, Hyderabad, India
 
448
13:30 INDIVIDUALS WITH CORONARY ARTERY DISEASE AT A YOUNG AGE AND FEATURES OF THE METABOLIC SYNDROME HAVE AN INCREASED PROTHROMBOTIC POTENTIAL
M.G. Kok, J.C. Meijer, S.J. Pinto-Sietsma, University of Amsterdam, Academic Medical Centre, Amsterdam, The Netherlands
 
449
13:45 PREVALENCE OF PERIPHERAL ARTERIAL DISEASE (PAD) BY MEANS OF ABI IN ASYMPTOMATIC TYPE II NORTH INDIAN DIABETICS AND ITS CORRELATION WITH CARDIOVASCULAR RISK MARKERS
R. Kapoor, R. Duggal, S. Kapoor, R. Kapoor Carewell Heart & Superspeciality Hospital, Amritsar, Punjab, India
 
450
14:00 EFFECT OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 ANTAGONISM ON ADIPOSITY IN OBESE MICE
H.R. Lijnen, I. Scroyen, Center for Molecular and Vascular Biology, KULeuven, Leuven, Belgium
 
 
14:15 LUNCH BREAK, VISIT POSTERS AND EXHIBITION  
 

 

Saturday,
July 27, 2013
Sunday,
July 28, 2013
Monday,
July 29, 2013
Oral Presentations Oral Presentations Oral Presentations
Poster Sessions Poster Sessions Poster Sessions

 

News

Reduced Registration Deadline:
July 15, 2013

Final Program now online. new

The scientific program of the 18th World Congress on Heart Disease has been reviewed by the American Medical Association and approved for a maximum of 25.75 AMA PRA Category 1 Credits™.

Publication of Abstracts: new
Abstracts were published in a special online only supplement issue of the journal CARDIOLOGY.
Click here to view.

 

 

. toronto


Affiliated with

 

    international academy of cardiology

Endorsed by